Clinical Trial Update: CDK4/6 Tumor, Abemaciclib, Paclitaxel [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/Phase 2 study of abemaciclib in combination with paclitaxel for tumors, with the study status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Abemaciclib (abemaciclib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Yonsei University | Conditions: Tumors | Phase 1, Phase 2 | Status: COMPLETED